INS and type 2 diabetes mellitus: Nonetheless, the comparable reductions in admission rates for severe hypoglycaemia in people with type 2 diabetes on multiple daily injections seen in both studies clearly suggest a preventive effect of isCGM on the acknowledged increased risks of severe hypoglycaemia for people with type 2 diabetes on intensive insulin therapy.